Full Text View
Tabular View
No Study Results Posted
Related Studies
131MIBG to Treat Malignant Pheochromocytoma
This study has been completed.
Study NCT00028106   Information provided by National Institutes of Health Clinical Center (CC)
First Received: December 11, 2001   Last Updated: August 22, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pheochromocytoma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Paraganglioma
Interventions listed in this trial
[131]I-MIBG
6-[18F]Fluorodopamine
[123]I-MIBG
Additional drug interventions recognized in this trial
3-Iodobenzylguanidine
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services